PACTR201507000984471已完成未知
Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries
Minoufiya university0 个研究点目标入组 50 人开始时间: 2014年12月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 32 Year(s) 至 75 Year(s)（—）
- 性别
- All
入选标准
- •ASA class II or III patients scheduled for cardiac surgery by using CPB
排除标准
- •age > 75 years, left ventricular ejection fraction (LVEF) < 55%, pre-existing severe LV hypertrophy, cardiomyopathies, grade II (pseudo-normal filling) and grade III (restrictive filling) diastolic dysfunction, preoperative atrial fibrillation , pericardial disease, drug dependence, cerebrovascular diseases, use of alpha 2 agonists ,type 1diabetes mellitus, renal disease, significant pulmonary disease and hepatic insufficiency.
研究者
相似试验
Unknown
不适用
Cardioprotective effects of Dexmedetomidine in patients with Ischemic Heart DiseasePACTR201711002757295doaa rashwan32
尚未招募
4 期
Renal protective effect of dexmeditomidine in patients undergoing abdominal aortic surgeriesAnaesthesiaPACTR202402909858685kafreelsheikh52
已完成
2 期
Cardio protective effect of dexmedetomidine in CABGmyocardial injury.Other functional disturbances following cardiac surgeryIRCT2016071113456N6Vice chancellor for research of Guilan University of Medical Sciences110
尚未招募
Unknown
Protective role of sedative agents on heart in open heart surgeries.CTRI/2023/06/053644AIIMS JODHPUR
招募中
3 期
europrotective effect of dexmedetomidine in brain tumor surgeryNervous System DiseasesAnaesthesiaCancerPACTR202008567047887Mona Raafat Elghamry40